Cangrelor
- Product NDC
- 68083-412
- 11-digit product format
- 680830412
- Labeler code
- 68083
- Product ID
- 68083-412_706b6332-5afe-498b-a846-788e6ebc6823
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cangrelor
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA213551
- Marketing category
- ANDA
- Marketing start
- 2025-08-11
- Substance
- CANGRELOR
- Active strength
- 50 mg/1
- Pharmacologic classes
- Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cangrelor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CANGRELOR | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6AQ1Y404U7 |
| Rxcui | 1656056 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68083-412-10 | Cangrelor | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
| 68083-412-10 | Cangrelor | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | | 6 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68083-412-10 | 68083041210 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | 2025-08-11 | No | No | Current |